Page last updated: 2024-09-04
(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and paclitaxel
(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide has been researched along with paclitaxel in 1 studies
Compound Research Comparison
| Studies ((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide) | Trials ((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide) | Recent Studies (post-2010) ((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
|---|---|---|---|---|---|
| 85 | 0 | 65 | 31,874 | 5,729 | 15,395 |
Protein Interaction Comparison
| Protein | Taxonomy | (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide (IC50) | paclitaxel (IC50) |
|---|---|---|---|
| Integrin beta-3 | Homo sapiens (human) | 0.034 | |
| Integrin alpha-V | Homo sapiens (human) | 0.034 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 2.598 | |
| Botulinum neurotoxin type A | Clostridium botulinum | 5.2 | |
| UDP-glucuronosyltransferase 2B7 | Homo sapiens (human) | 4.9 | |
| UDP-glucuronosyltransferase 1-6 | Homo sapiens (human) | 4.9 | |
| Substance-K receptor | Homo sapiens (human) | 6.125 | |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | 4.9 | |
| UDP-glucuronosyltransferase 1A4 | Homo sapiens (human) | 4.9 | |
| UDP-glucuronosyltransferase 2B10 | Homo sapiens (human) | 4.9 | |
| Delta-type opioid receptor | Homo sapiens (human) | 4.202 | |
| Tyrosine-protein kinase Mer | Homo sapiens (human) | 4.9 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 0.0082 | |
| Beta-tubulin | Leishmania donovani | 1 | |
| Nucleotide-binding oligomerization domain-containing protein 2 | Homo sapiens (human) | 7.9433 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 0.26 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 0.28 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Abe, K; Chiba, T; Kamata, Y; Kambe, T; Kawakami, K; Taguchi, K; Yamamoto, K | 1 |
Other Studies
1 other study(ies) available for (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and paclitaxel
| Article | Year |
|---|---|
Paclitaxel Induces Upregulation of Transient Receptor Potential Vanilloid 1 Expression in the Rat Spinal Cord.
Topics: Acrylamides; Animals; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Hyperalgesia; Injections, Intraperitoneal; Injections, Spinal; Male; Paclitaxel; Rats; RNA, Small Interfering; Spinal Cord; TRPV Cation Channels; Up-Regulation | 2020 |